Order Article Reprints

Ferrer MD, Reynés C, Monserrat-Mesquida M, Quetglas-Llabrés M, Bouzas C, García S, Mateos D, Casares M, Gómez C, Ugarriza L, et al. Polyunsaturated and Saturated Oxylipin Plasma Levels Allow Monitoring the Non-Alcoholic Fatty Liver Disease Progression to Severe Stages. Antioxidants. 2023; 12(3):711. https://doi.org/10.3390/antiox12030711

Ferrer, Miguel D., Clara Reynés, Margalida Monserrat-Mesquida, Magdalena Quetglas-Llabrés, Cristina Bouzas, Silvia García, David Mateos, Miguel Casares, Cristina Gómez, Lucía Ugarriza, and et al. 2023. "Polyunsaturated and Saturated Oxylipin Plasma Levels Allow Monitoring the Non-Alcoholic Fatty Liver Disease Progression to Severe Stages" Antioxidants 12, no. 3: 711. https://doi.org/10.3390/antiox12030711

Ferrer, M. D., Reynés, C., Monserrat-Mesquida, M., Quetglas-Llabrés, M., Bouzas, C., García, S., Mateos, D., Casares, M., Gómez, C., Ugarriza, L., Tur, J. A., Sureda, A., & Pons, A. (2023). Polyunsaturated and Saturated Oxylipin Plasma Levels Allow Monitoring the Non-Alcoholic Fatty Liver Disease Progression to Severe Stages. Antioxidants, 12(3), 711. https://doi.org/10.3390/antiox12030711